Solid Biosciences Inc. SLDB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $297.1M+41.1% | $59.9M-25.3% | $61.36M-4.7% | $138.93M+44.9% | $210.63M+79.1% | ||
| $83.58M-13.2% | $127.95M+86.3% | $174.78M+63.8% | $129.18M+36.8% | $96.29M+8.8% | ||
| $638K— | $1.22M— | $1.92M-0.4% | $1.92M+0.7% | $0-100% | ||
| $15.47M+138% | $16.38M+95.5% | $8.71M+4.0% | $10.53M+43.4% | $6.49M-20.1% | ||
| $396.79M+26.6% | $205.46M+30.6% | $244.85M+36.4% | $278.64M+41.0% | $313.41M+46.3% | ||
| $3.91M-12.7% | $4.17M-12.2% | $4.36M-14.0% | $4.32M-20.6% | $4.48M-29.9% | ||
| $21.3M-10.2% | $21.92M-9.8% | $22.54M-9.3% | $23.13M-9.3% | $23.72M-9.1% | ||
| $183K-42.6% | $223K-39.1% | $247K-48.0% | $278K-46.0% | $319K+82.3% | ||
| $26.11M-14.4% | $27.08M-13.6% | $29.06M-10.1% | $29.65M-11.1% | $30.5M— | ||
| $422.89M+23.0% | $232.54M+23.3% | $273.91M+29.3% | $308.29M+33.5% | $343.9M+38.3% | ||
| $5.56M-13.6% | $3.22M-23.9% | $8.43M+144% | $4.7M+86.6% | $6.44M+272% | ||
| $19.18M+31.6% | $18.95M-4.6% | $19.05M+44.0% | $16.55M+66.8% | $14.58M+15,743% | ||
| $2.19M+17.1% | $2.1M+17.7% | $2.03M+18.3% | $1.94M+12.7% | $1.87M+10.3% | ||
| $30.28M+5.2% | $33.47M+10.6% | $36.34M+59.0% | $29.85M+103% | $28.78M+101% | ||
| $18.48M-10.6% | $19.06M-9.9% | $19.62M-9.3% | $20.16M-8.8% | $20.66M-8.3% | ||
| —— | —— | —— | —— | —— | ||
| $18.48M-10.6% | $19.06M-9.9% | $19.62M-10.6% | $20.16M-12.6% | $20.66M— | ||
| $48.76M-1.4% | $52.53M+2.2% | $55.97M+24.9% | $50M+32.5% | $49.44M+30.2% | ||
| —— | —— | —— | —— | —— | ||
| $98K+27.3% | $79K+97.5% | $78K+100% | $78K+100% | $77K+103% | ||
| $1.39B+24.3% | $1.14B+23.6% | $1.13B+24.0% | $1.12B+24.3% | $1.12B+25.0% | ||
| -$1.01B-23.3% | -$957.78M-22.3% | -$907.99M-22.6% | -$862.21M-21.8% | -$822.73M-20.4% | ||
| -$13K-750% | $52K+10.6% | $48K-58.6% | -$38K-153% | $2K+150% | ||
| $374.13M+27.1% | $180.01M+31.2% | $217.95M+30.5% | $258.29M+33.7% | $294.46M+39.7% | ||
| $422.89M+23.0% | $232.54M+23.3% | $273.91M+29.3% | $308.29M+33.5% | $343.9M+38.3% | ||
| $83.58M-13.2% | $127.95M+86.3% | $174.78M+63.8% | $129.18M+36.8% | $96.29M+8.8% | ||
| $183K-42.6% | $223K-39.1% | $247K-48.0% | $278K-46.0% | $319K+82.3% | ||
| $21.3M-10.2% | $21.92M-9.8% | $22.54M-9.3% | $23.13M-9.3% | $23.72M-9.1% | ||
| $21.3M-10.2% | $21.92M-9.8% | $22.54M-9.3% | $23.13M-9.3% | $23.72M-9.1% | ||
| $183K-42.6% | $223K-39.1% | $247K-48.0% | $278K-46.0% | $319K+82.3% | ||
| $21.3M-10.2% | $21.92M-9.8% | $22.54M-9.3% | $23.13M-9.3% | $23.72M-9.1% | ||
| $183K-42.6% | $223K-39.1% | $247K-48.0% | $278K-46.0% | $319K+82.3% | ||
| $19.18M+31.6% | $18.95M-4.6% | $19.05M+44.0% | $16.55M+66.8% | $14.58M+41.1% | ||
| $19.18M+31.6% | $18.95M-4.6% | $19.05M+44.0% | $16.55M+66.8% | $14.58M+41.1% | ||
| $3.35M-30.2% | $9.2M+192% | $6.55M+92.6% | $5.7M— | $4.8M— | ||
| $3.35M-30.2% | $9.2M+192% | $6.55M+92.6% | $5.7M— | $4.8M— | ||
| $20.67M-12.5% | $21.16M-12.5% | $21.94M-11.3% | $23.05M-8.9% | $23.63M-8.5% | ||
| $1.39B+24.3% | $1.14B+23.6% | $1.13B+24.0% | $1.12B+24.3% | $1.12B+25.0% | ||
| $98K+27.3% | $79K+97.5% | $78K+100% | $78K+100% | $77K+103% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Solid Biosciences Inc.'s total assets?
- Solid Biosciences Inc. (SLDB) holds $422.9M in total assets, up 23.0% year over year.
- How much debt does Solid Biosciences Inc. have?
- Solid Biosciences Inc. carries $20.7M in total debt against $374.1M of shareholders' equity, a debt-to-equity ratio of 0.06.
- How much cash does Solid Biosciences Inc. have?
- Solid Biosciences Inc. holds $297.1M in cash and equivalents.
- Can Solid Biosciences Inc. cover its short-term obligations?
- Its current ratio is 13.10 — current assets exceed current liabilities.
- Where does Solid Biosciences Inc.'s balance sheet data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
